Nebula Research & Development LLC Keros Therapeutics, Inc. Transaction History
Nebula Research & Development LLC
- $1.08 Trillion
- Q1 2025
A detailed history of Nebula Research & Development LLC transactions in Keros Therapeutics, Inc. stock. As of the latest transaction made, Nebula Research & Development LLC holds 115,420 shares of KROS stock, worth $1.67 Million. This represents 0.11% of its overall portfolio holdings.
Number of Shares
115,420
Previous 71,710
60.95%
Holding current value
$1.67 Million
Previous $1.14 Billion
3.61%
% of portfolio
0.11%
Previous 0.13%
Shares
4 transactions
Others Institutions Holding KROS
# of Institutions
180Shares Held
36.6MCall Options Held
938KPut Options Held
1.39M-
Nuveen, LLC Charlotte, NC3.95MShares$57.1 Million0.01% of portfolio
-
Jpmorgan Chase & CO New York, NY2.6MShares$37.6 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.57MShares$37.1 Million0.0% of portfolio
-
Black Rock Inc. New York, NY2.51MShares$36.3 Million0.0% of portfolio
-
Logos Global Management LP San Francisco, CA2MShares$28.9 Million3.97% of portfolio
About Keros Therapeutics, Inc.
- Ticker KROS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 25,757,000
- Market Cap $372M
- Description
- Keros Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of novel treatments for patients suffering from hematological and musculoskeletal disorders with high unmet medical need. The company's lead protein therapeutic product candidate is KER-050, which is being developed ...